HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rocke, D. A. Articles by Brock-Utine, J. G. Search for Related Content PubMed PubMed Citation Articles by Rocke, D. A. Articles by Brock-Utine, J. G.

The Journal of Thoracic and Cardiovascular Surgery, Vol 93, 832-837, Copyright © 1987 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Endotoxemia associated with cardiopulmonary bypass

DA Rocke, SL Gaffin, MT Wells, Y Koen and JG Brock-Utine

Endotoxin (lipopolysaccharide) concentrations were determined in the systemic venous blood in nine patients undergoing cardiopulmonary bypass. Lipopolysaccharide concentrations were low and stable until institution of cardiopulmonary bypass (preanesthetic concentration 0.128 +/- 0.032 ng/ml [mean +/- standard error of the mean]; prebypass level 0.136 +/- 0.03 ng/ml). After the start of bypass, the plasma concentration of lipopolysaccharide rose progressively with time to a mean value of 0.347 +/- 0.044 ng/ml (p less than 0.01), which was 0.227 ng/ml above baseline. Upon release of the aortic clamp, an additional rise in lipopolysaccharide concentration occurred after to 5 to 15 minutes to a mean value of 0.428 +/- 0.06 ng/ml (p less than 0.001) above baseline. The concentration then decayed to the baseline level 45 to 75 minutes after termination of bypass. The peak lipopolysaccharide concentration above the baseline positively correlated with both the length of bypass (r = 0.839, p less than 0.005) and the duration of aortic cross-clamping (y = 0.0030X + 0.173 r = 0.85, p less than 0.001) when flow was nonpulsatile. The peak occurred during the period of myocardial and pulmonary reperfusion. This rise in endotoxin concentration may be one of the factors responsible for the prolonged postoperative recovery seen in some patients.

This article has been cited by other articles:

				J. W. Hammon Extracorporeal Circulation: The Response of Humoral and Cellular Elements of Blood to Extracorporeal Circulation Card. Surg. Adult, January 1, 2008; 3(2008): 370 - 389. [Full Text]

				E. Bennett-Guerrero, H. P. Grocott, J. H. Levy, K. A. Stierer, C. W. Hogue, A. T. Cheung, M. F. Newman, A. A. Carter, D. P. Rossignol, and C. D. Collard A Phase II, Double-Blind, Placebo-Controlled, Ascending-Dose Study of Eritoran (E5564), a Lipid A Antagonist, in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass Anesth. Analg., February 1, 2007; 104(2): 378 - 383. [Abstract] [Full Text] [PDF]

				P. K. Smith, M. Carrier, J. C. Chen, A. Haverich, J. H. Levy, P. Menasche, S. K. Shernan, F. Van de Werf, P. X. Adams, T. G. Todaro, et al. Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time. Ann. Thorac. Surg., September 1, 2006; 82(3): 781 - 788. [Abstract] [Full Text] [PDF]

				A. Haverich, S. K. Shernan, J. H. Levy, J. C. Chen, M. Carrier, K. M. Taylor, F. Van de Werf, M. F. Newman, P. X. Adams, T. G. Todaro, et al. Pexelizumab Reduces Death and Myocardial Infarction in Higher Risk Cardiac Surgical Patients Ann. Thorac. Surg., August 1, 2006; 82(2): 486 - 492. [Abstract] [Full Text] [PDF]

				R. Ascione, S. Talpahewa, C. Rajakaruna, B. C. Reeves, A. T. Lovell, A. Cohen, and G. D. Angelini Splanchnic Organ Injury During Coronary Surgery With or Without Cardiopulmonary Bypass: A Randomized, Controlled Trial Ann. Thorac. Surg., January 1, 2006; 81(1): 97 - 103. [Abstract] [Full Text] [PDF]

				J. P. Mathew, S. K. Shernan, W. D. White, J. C.K. Fitch, J. C. Chen, L. Bell, and M. F. Newman Preliminary Report of the Effects of Complement Suppression With Pexelizumab on Neurocognitive Decline After Coronary Artery Bypass Graft Surgery Stroke, October 1, 2004; 35(10): 2335 - 2339. [Abstract] [Full Text] [PDF]

				E. A. Hessel II Abdominal Organ Injury After Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2004; 8(3): 243 - 263. [Abstract] [PDF]

				S. K. Shernan, J. C. K. Fitch, N. A. Nussmeier, J. C. Chen, S. A. Rollins, C. F. Mojcik, K. J. Malloy, T. G. Todaro, T. Filloon, S. W. Boyce, et al. Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass Ann. Thorac. Surg., March 1, 2004; 77(3): 942 - 949. [Abstract] [Full Text] [PDF]

				N. B. Aydin, H. Gercekoglu, B. Aksu, V. Ozkul, T. Sener, I. Kiygil, T. Turkoglu, S. Cimen, F. Babacan, and M. Demirtas Endotoxemia in coronary artery bypass surgery: A comparison of the off-pump technique and conventional cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 843 - 848. [Abstract] [Full Text] [PDF]

				P. Menasche and L. H. Edmunds Jr. Extracorporeal Circulation: The Inflammatory Response Card. Surg. Adult, January 1, 2003; 2(2003): 349 - 360. [Full Text]

				T. K. Andresen, J. L Svennevig, and V. Videm Soluble VCAM-1 is a very early marker of endothelial cell activation in cardiopulmonary bypass Perfusion, January 1, 2002; 17(1): 15 - 21. [Abstract] [PDF]

				H. A. Hennein Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255. [Abstract] [PDF]

				M. Rothenburger, R. Soeparwata, M. C. Deng, E. Berendes, C. Schmid, T. D. T. Tjan, M. J. Wilhelm, M. Erren, D. Bocker, and H. H. Scheld The impact of anti-endotoxin core antibodies on endotoxin and cytokine release and ventilation time after cardiac surgery J. Am. Coll. Cardiol., July 1, 2001; 38(1): 124 - 130. [Abstract] [Full Text] [PDF]

				V. Videm, J. L Svennevig, E. Fosse, B. Mohr, and A. O Aasen Plasma endotoxin concentrations during cardiac surgery may be related to atherosclerosis Perfusion, September 1, 2000; 15(5): 421 - 426. [Abstract] [PDF]

				R. Munoz, P. C. Laussen, G. Palacio, L. Zienko, G. Piercey, and D. L. Wessel CHANGES IN WHOLE BLOOD LACTATE LEVELS DURING CARDIOPULMONARY BYPASS FOR SURGERY FOR CONGENITAL CARDIAC DISEASE: AN EARLY INDICATOR OF MORBIDITY AND MORTALITY J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 155 - 162. [Abstract] [Full Text] [PDF]

				J. Petaja, E. Pesonen, J. A. Fernandez, A. E. Vento, O. J. Ramo, and J. H. Griffin CARDIOPULMONARY BYPASS AND ACTIVATION OF ANTITHROMBOTIC PLASMA PROTEIN C J. Thorac. Cardiovasc. Surg., September 1, 1999; 118(3): 422 - 429. [Abstract] [Full Text] [PDF]

				S. Wan, J.-L. LeClerc, C.-H. Huynh, D. Schmartz, J.-M. DeSmet, A. P.C. Yim, and J.-L. Vincent DOES STEROID PRETREATMENT INCREASE ENDOTOXIN RELEASE DURING CLINICAL CARDIOPULMONARY BYPASS? J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 1004 - 1008. [Abstract] [Full Text] [PDF]

				A. L. Picone, C. J. Lutz, C. Finck, D. Carney, L. A. Gatto, A. Paskanik, B. Searles, K. Snyder, and G. Nieman Multiple sequential insults cause post-pump syndrome Ann. Thorac. Surg., April 1, 1999; 67(4): 978 - 985. [Abstract] [Full Text] [PDF]

				L. A. Brasil, W. J. Gomes, R. Salomao, and E. Buffolo Inflammatory response after myocardial revascularization with or without cardiopulmonary bypass Ann. Thorac. Surg., July 1, 1998; 66(1): 56 - 59. [Abstract] [Full Text] [PDF]

				J. S. Steingrub Novel Insights Into the Pathogenesis and Therapy of Circulatory Shock Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1998; 2(1): 31 - 45. [Abstract] [PDF]

				S. Wan, J.-L. LeClerc, and J.-L. Vincent Cytokine Responses to Cardiopulmonary Bypass: Lessons Learned From Cardiac Transplantation Ann. Thorac. Surg., January 1, 1997; 63(1): 269 - 276. [Abstract] [Full Text]

				K. M. Taylor SIRS-The Systemic Inflammatory Response Syndrome After Cardiac Operations Ann. Thorac. Surg., June 1, 1996; 61(6): 1607 - 1608. [Full Text]

				J. Cremer, M. Martin, H. Redl, S. Bahrami, C. Abraham, T. Graeter, A. Haverich, G. Schlag, and H.-G. Borst Systemic Inflammatory Response Syndrome After Cardiac Operations Ann. Thorac. Surg., June 1, 1996; 61(6): 1714 - 1720. [Abstract] [Full Text]

				M. Miyama, W. C. Dihmis, P. H. Deleuze, Y. Uozaki, S. L. Bambang, F. Pasteau, N. Rostaqui, and D. Y. Loisance The Gastrointestinal Tract: An Underestimated Organ as Demonstrated in an Experimental LVAD Pig Model Ann. Thorac. Surg., March 1, 1996; 61(3): 817 - 822. [Abstract] [Full Text]

				H. t. Velthuis, P. G. M. Jansen, H. M. Oudemans-van Straaten, G. J. van Kamp, A. Sturk, L. Eijsman, and C. R. H. Wildevuur Circulating Endothelin in Cardiac Operations: Influence of Blood Pressure and Endotoxin Ann. Thorac. Surg., March 1, 1996; 61(3): 904 - 908. [Abstract] [Full Text]

				H. t. Velthuis, P. G. M. Jansen, H. M. Oudemans-van Straaten, A. Sturk, L. Eijsman, and C. R. H. Wildevuur MYOCARDIAL PERFORMANCE IN ELDERLY PATIENTS AFTER CARDIOPULMONARY BYPASS IS SUPPRESSED BY TUMOR NECROSIS FACTOR J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1663 - 1669. [Abstract] [Full Text]

				R. M. Engelman, J. A. Rousou, J. E. Flack III, D. W. Deaton, R. Kalfin, and D. K. Das Influence of Steroids on Complement and Cytokine Generation After Cardiopulmonary Bypass Ann. Thorac. Surg., September 1, 1995; 60(3): 801 - 804. [Abstract] [Full Text]

				C. T Bowles, S. K Ohri, N. Klangsuk, B. E Keogh, M. H Yacoub, and K. M Taylor Endotoxaemia detected during cardiopulmonary bypass with a modified Limulus amoebocyte lysate assay Perfusion, July 1, 1995; 10(4): 219 - 228. [Abstract] [PDF]

				J. P. A. M. Schonberger, P. A. M. Everts, and J. J. Hoffmann Systemic Blood Activation With Open and Closed Venous Reservoirs Ann. Thorac. Surg., June 1, 1995; 59(6): 1549 - 1555. [Abstract] [Full Text]

				S. Watarida, A. Mori, M. Onoe, R. Tabata, S. Shiraishi, T. Sugita, T. Nojima, Y. Nakajima, and S. Matsuno A clinical study on the effects of pulsatile cardiopulmonary bypass on the blood endotoxin levels J. Thorac. Cardiovasc. Surg., October 1, 1994; 108(4): 620 - 625. [Abstract] [Full Text]

				S.K. Ohri, C.T. Bowles, A. Siddiqui, A. Khaghani, B.E. Keogh, G. Wright, M.H. Yacoub, and K.M. Taylor The effect of cardiopulmonary bypass on gastric and colonic mucosal perfusion: a tonometric assessment Perfusion, March 1, 1994; 9(2): 101 - 108. [Abstract] [PDF]

				P. Menasche, S. Haydar, J. Peynet, C. D. Buit, R. Merval, G. Bloch, A. Piwnica, and A. Tedgui A potential mechanism of vasodilation after warm heart surgery: The temperature-dependent release of cytokines J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 293 - 299. [Abstract] [Full Text]

				L. Andersen and L. Baek Transient endotoxaemia during cardiac surgery Perfusion, January 1, 1992; 7(1): 53 - 58. [PDF]

				J. Laidler, M. Paes, J. Wheeler, R. Freeman, and H. Robertson Detection of circulating tumour necrosis factor-{alpha} after elective cardiopulmonary bypass Perfusion, January 1, 1991; 6(1): 51 - 54. [Abstract] [PDF]